Business Wire (Free subscription) | yesterday
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue. World Molecular Diagnostics Market
Multi-Lingual Medical Knowledge (Free subscription) | 09/11/2008
Description: This updated and expanded tutorial guide to molecular diagnostic techniques takes advantage of many new molecular technologies to include both improved traditional methods and totally new methods, some not yet in routine use. The authors offer cutting-edge molecular diagnostics for genetic disease, human cancers, infectious diseases, and identity testing, as well as new insights into the...
Red Orbit (Free subscription) | 31/10/2008
PLEASANTON, Calif., Oct. 30 /PRNewswire/ -- Roche Molecular Diagnostics today announced that the U.S. Food & Drug Administration (FDA) has approved the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test for use in the United States.
Market Wire - Medical and Healthcare: Medical Devices (Free subscription) | 29/10/2008
BEVERLY, MA (MARKET WIRE) Enzymatics (http://www.enzymatics.com), specializing in the large-scale production of high quality enzymes, including a wide-range of enzymes for DNA sequencing and diagnostics, has implemented ISO 13485:2003.
Fiercebiotech (Free subscription) | 16/10/2008
Molecular diagnostics company Predictive Biosciences has closed a $21.75 million Series B round of financing. New Enterprise Associates and Kaiser Permanente Ventures led the round. The company is developing non-invasive diagnostic products for cancer management and exploring the application of its assays in breast, prostate, ovarian and colorectal cancers. Predictive plans to use the funding to complete...
Hindu (Free subscription) | 10/10/2008
TIRUCHI: The Department of Biotechnology (DBT), New Delhi, has offered Rs. 75.15 lakh to Bharathidasan University to offer advanced diploma course in Molecular Diagnostics to train post graduates from life sciences. The course is being ...
Hindu (Free subscription) | 09/10/2008
TIRUCHI: The Department of Biotechnology (DBT), New Delhi, has offered Rs. 75.15 lakh to Bharathidasan University to offer advanced diploma course in Molecular Diagnostics to train post graduates from life sciences. The course is being ...
Red Orbit (Free subscription) | 09/10/2008
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Market Wire (Free subscription) | 09/10/2008
LONDON, UNITED KINGDOM (MARKET WIRE) Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Seeking Alpha (Free subscription) | 08/10/2008
ChinaBio Today submits: China Medical Technologies (CMED), which produces in-vitro diagnostic products, will pay $345 million to purchase the rights for a human papillomavirus ((HPV)) test from Molecular Diagnostics Technologies Limited. China Medical will buy the HPV-DNA Biosensor Chip and Surface Plasmon Resonance-based Analysis System (the SPR System), which can detect the virus that causes cervical...
Medical News Today (Free subscription) | 06/10/2008
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN). The payoff for successful molecular diagnostic products can be significant as Kalorama Information predicts that this market currently exceeds $3.2 billion worldwide and will reach $5.4 billion in four years, according to an...
bizjournals (Free subscription) | 06/10/2008
Biotechnology Molecular diagnostics company Asuragen Inc. has granted Focus Diagnostics Inc., an infectious disease diagnostics business, nonexclusive worldwide rights to incorporate its Armored RNA technology into Focus’ in vitro molecular diagnostics products.
Science Daily (Free subscription) | 03/10/2008
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News. The payoff for successful molecular diagnostic products can be significant as Kalorama Information predicts that this market currently exceeds $3.2 billion worldwide and will reach $5.4 billion in four years.
The East Bay Business Times (Free subscription) | 25/09/2008
Molecular diagnostics company Vermillion Inc. said it has been notified by Nasdaq that its securities will be delisted beginning Thursday.
bizjournals (Free subscription) | 25/09/2008
Molecular diagnostics company Vermillion Inc. said it has been notified by Nasdaq that its securities will be delisted beginning Thursday.
